Skip to main content
Erschienen in: The journal of nutrition, health & aging 7/2018

19.02.2018

Diagnosis of Sarcopenia in Long-Term Care Homes for the Elderly: The Sensitivity and Specificity of Two Simplified Algorithms with Respect to the EWGSOP Consensus

verfasst von: A. I. Rodriguez-Rejon, Reyes Artacho, A. Puerta, A. Zuñiga, M. D. Ruiz-Lopez

Erschienen in: The journal of nutrition, health & aging | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Objective

To analyze the prevalence of sarcopenia in elderly care homes using the algorithm of the European Working Group on Sarcopenia in Older People (EWGSOP) and to evaluate the applicability, sensitivity, and specificity of two simplified algorithms that do not include gait speed measurement.

Design

Cross-sectional study.

Setting

Long-term care homes.

Participants

249 residents (187 females and 62 males) with a mean age of 84.9 ± 6.7 years (range, 70–106 yrs).

Measurements

Cognitive impairment was evaluated with the Pfeiffer test, functional capacity with the Barthel index, walking ability by the Functional Ambulation Classification, muscle mass by bioelectrical impedance analysis, muscle strength by handgrip dynamometry and, gait speed over a distance of 4 m. Sarcopenia was assessed using the EWGSOP-recommended algorithm and two simplified algorithms (A and B). Algorithms A and B were validated with respect to the EWGSOP algorithm using the MacNemar test and obtaining the sensitivity and specificity, kappa coefficient, and area under the receiver operating characteristic curve (AUC).

Results

Total or severe dependence was recorded in 67% of the 249 residents, severe or moderate cognitive impairment in 64%, inability to walk in 49%, and capacity to walk only with the aid of an ambulator or two people in 21%. The prevalence of sarcopenia was 63.0% by the EWGSOP algorithm, 62.9% by algorithm A and 63.2% by algorithm B (P = 1.000); 143 participants were diagnosed with sarcopenia by all three methods (P =1.000, K = 1.000).

Conclusion

Further studies that include residents with functional and/or cognitive impairment are required to validate these results, comparing the diagnostic performance of the EGWSOP algorithm with that of the simplified algorithms validated in the present report.
Literatur
2.
Zurück zum Zitat Malafarina V, Uriz-Otano F, Gil-Guerrero L et al. Nutritional assessment and treatment of sarcopenia. Rev Esp Geriatr Gerontol 2013;48: 153–154CrossRefPubMed Malafarina V, Uriz-Otano F, Gil-Guerrero L et al. Nutritional assessment and treatment of sarcopenia. Rev Esp Geriatr Gerontol 2013;48: 153–154CrossRefPubMed
3.
Zurück zum Zitat Cruz-Jentoft AJ, Landi F, Schneider SM et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the international sarcopenia initiative (EWGSOP and IWGS). Age Ageing 2014;43(6):48–759CrossRef Cruz-Jentoft AJ, Landi F, Schneider SM et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the international sarcopenia initiative (EWGSOP and IWGS). Age Ageing 2014;43(6):48–759CrossRef
4.
Zurück zum Zitat Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyère O. Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One 2017;12(1):e0169548CrossRefPubMedPubMedCentral Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyère O. Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One 2017;12(1):e0169548CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Ethgen O, Beaudart C, Buckinx F, Bruyere O, Reginster JY. The future prevalence of sarcopenia in Europe: a claim for public health action. Calcif Tissue Int 2017;100(3):229–34CrossRefPubMed Ethgen O, Beaudart C, Buckinx F, Bruyere O, Reginster JY. The future prevalence of sarcopenia in Europe: a claim for public health action. Calcif Tissue Int 2017;100(3):229–34CrossRefPubMed
6.
Zurück zum Zitat González-Montalvo JI, Alarcón T, Gotor P et al. Prevalence of sarcopenia in acute hip fracture patients and its influence on short-term clinical outcome. Geriatr Gerontol Int 2016;16(9):1021–7CrossRefPubMed González-Montalvo JI, Alarcón T, Gotor P et al. Prevalence of sarcopenia in acute hip fracture patients and its influence on short-term clinical outcome. Geriatr Gerontol Int 2016;16(9):1021–7CrossRefPubMed
7.
Zurück zum Zitat Bianchi L, Ferrucci L, Cherubini A, Maggio M, Bandinelli S, Savino E, Brombo G, Zuliani G, Guralnik JM, Landi F, Volpato S. The predictive value of the EWGSOP definition of sarcopenia: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2016;71(2):259–64CrossRefPubMed Bianchi L, Ferrucci L, Cherubini A, Maggio M, Bandinelli S, Savino E, Brombo G, Zuliani G, Guralnik JM, Landi F, Volpato S. The predictive value of the EWGSOP definition of sarcopenia: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2016;71(2):259–64CrossRefPubMed
8.
Zurück zum Zitat Bianchi L, Abete P, Bellelli G et al. Prevalence and clinical correlates of sarcopenia, identified according to the EWGSOP definition and diagnostic algorithm, in hospitalized older people: the GLISTEN study. J Gerontol A Biol Sci Med Sci 2017; 72(11):1575–81CrossRefPubMed Bianchi L, Abete P, Bellelli G et al. Prevalence and clinical correlates of sarcopenia, identified according to the EWGSOP definition and diagnostic algorithm, in hospitalized older people: the GLISTEN study. J Gerontol A Biol Sci Med Sci 2017; 72(11):1575–81CrossRefPubMed
9.
Zurück zum Zitat Yoshida D, Suzuki T, Shimada H et al. Using two different algorithms to determine the prevalence of sarcopenia. Geriatr Gerontol Int 2014;14(Suppl.1):46–51CrossRefPubMed Yoshida D, Suzuki T, Shimada H et al. Using two different algorithms to determine the prevalence of sarcopenia. Geriatr Gerontol Int 2014;14(Suppl.1):46–51CrossRefPubMed
10.
Zurück zum Zitat Manatunga AK, Hudgens M & Chen S. Sample size estimation in cluster randomized studies with varying cluster size. Control Clin Trials 1998;43:75–86 Manatunga AK, Hudgens M & Chen S. Sample size estimation in cluster randomized studies with varying cluster size. Control Clin Trials 1998;43:75–86
11.
Zurück zum Zitat Holden MK, Gill KM, Magliozzi MR, Nathan J, Piehl-Baker L. Clinical gait assessment in the neurologically impaired: reliability and meaningfulness. Phys Ther 1984;64:35–40.CrossRefPubMed Holden MK, Gill KM, Magliozzi MR, Nathan J, Piehl-Baker L. Clinical gait assessment in the neurologically impaired: reliability and meaningfulness. Phys Ther 1984;64:35–40.CrossRefPubMed
12.
Zurück zum Zitat Berral de la Rosa F & Del Águila-Quirós D. Nutritional / anthropometric assessment of patients staying in bed or at hospital. Arch Med del Deport 2002;19(88):129–35 Berral de la Rosa F & Del Águila-Quirós D. Nutritional / anthropometric assessment of patients staying in bed or at hospital. Arch Med del Deport 2002;19(88):129–35
13.
Zurück zum Zitat Masanes F, Culla A, Navarro-Gonzalez M, Navarro-Lopez M, Sacanella E, Torres B, López-Soto A. Prevalence of sarcopenia in healthy community-dwelling elderly in an urban area of Barcelona (Spain). J Nutr Health Aging 2012;16(2):184–7CrossRefPubMed Masanes F, Culla A, Navarro-Gonzalez M, Navarro-Lopez M, Sacanella E, Torres B, López-Soto A. Prevalence of sarcopenia in healthy community-dwelling elderly in an urban area of Barcelona (Spain). J Nutr Health Aging 2012;16(2):184–7CrossRefPubMed
14.
Zurück zum Zitat Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 2000;89(2):465–71.CrossRefPubMed Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 2000;89(2):465–71.CrossRefPubMed
15.
Zurück zum Zitat Ruiz-Ruiz J, Mesa JL, Gutiérrez A, Castillo MJ. Hand size influences optimal grip span in women but not in men. J Hand Surg Am 2002;27(5):897–901CrossRefPubMed Ruiz-Ruiz J, Mesa JL, Gutiérrez A, Castillo MJ. Hand size influences optimal grip span in women but not in men. J Hand Surg Am 2002;27(5):897–901CrossRefPubMed
16.
Zurück zum Zitat Díaz-Muñoz GA, Cárdenas-Zuluaga DM, Mesa-Jiménez A. Consistency of Mini Nutritional Assessment to identify sarcopenia in older adults in nursing homes in Bogota, Colombia. Nutr Hosp 2015;32(1):270–4PubMed Díaz-Muñoz GA, Cárdenas-Zuluaga DM, Mesa-Jiménez A. Consistency of Mini Nutritional Assessment to identify sarcopenia in older adults in nursing homes in Bogota, Colombia. Nutr Hosp 2015;32(1):270–4PubMed
17.
Zurück zum Zitat Rahman TTA, Farid HM, Elkholy NM, Mortagy AK. Prevalence of sarcopenia among nursing home older residents in Cairo, Egypt. Adv Aging Res 2014;43(4):118–23CrossRef Rahman TTA, Farid HM, Elkholy NM, Mortagy AK. Prevalence of sarcopenia among nursing home older residents in Cairo, Egypt. Adv Aging Res 2014;43(4):118–23CrossRef
18.
Zurück zum Zitat Saka B, Ozkaya H, Karisik E et al. Malnutrition and sarcopenia are associated with increased mortality rate in nursing home residents: a prospective study. Eur Geriatr Med 2016;7(3):232–8CrossRef Saka B, Ozkaya H, Karisik E et al. Malnutrition and sarcopenia are associated with increased mortality rate in nursing home residents: a prospective study. Eur Geriatr Med 2016;7(3):232–8CrossRef
19.
Zurück zum Zitat Salvà A, Serra-Rexach JA, Artaza I el al. Prevalence of sarcopenia in Spanish nursing homes: comparison of the results of the ELLI study with other populations. Rev Esp Geriatr Gerontol 2016;51(5):260–4CrossRefPubMed Salvà A, Serra-Rexach JA, Artaza I el al. Prevalence of sarcopenia in Spanish nursing homes: comparison of the results of the ELLI study with other populations. Rev Esp Geriatr Gerontol 2016;51(5):260–4CrossRefPubMed
20.
Zurück zum Zitat Sarabia-Cobo CM, Pérez-Rugosa V, Hermosilla-Grijalbo C, Núñez-García MJ, De-Lorena-Quintal P. Prevalencia de sarcopenia en mayores con demencia institucionalizados. Metas Enferm 2015;18(6):17–21 Sarabia-Cobo CM, Pérez-Rugosa V, Hermosilla-Grijalbo C, Núñez-García MJ, De-Lorena-Quintal P. Prevalencia de sarcopenia en mayores con demencia institucionalizados. Metas Enferm 2015;18(6):17–21
21.
Zurück zum Zitat Senior HE, Henwood TR, Beller EM, Mitchell GK, Keogh JWL. Prevalence and risk factors of sarcopenia among adults living in nursing homes. Maturitas 2015;82(4):418–23CrossRefPubMed Senior HE, Henwood TR, Beller EM, Mitchell GK, Keogh JWL. Prevalence and risk factors of sarcopenia among adults living in nursing homes. Maturitas 2015;82(4):418–23CrossRefPubMed
22.
Zurück zum Zitat Steffl M, Musalek M, Kramperova V, Petr M, Kohlikova E, Holmerova I, Volicer L. Assessment of diagnostics tools for sarcopenia severity using the item response theory (IRT). J Nutr Health Aging 2016;20(10):1051–5CrossRefPubMed Steffl M, Musalek M, Kramperova V, Petr M, Kohlikova E, Holmerova I, Volicer L. Assessment of diagnostics tools for sarcopenia severity using the item response theory (IRT). J Nutr Health Aging 2016;20(10):1051–5CrossRefPubMed
23.
Zurück zum Zitat Yalcin A, Aras S, Atmis V, Cengiz OK, Varli M, Cinar E, Atli T. Sarcopenia prevalence and factors associated with sarcopenia in older people living in a nursing home in Ankara Turkey. Geriatr Gerontol Int 2016;16(8):903–10CrossRefPubMed Yalcin A, Aras S, Atmis V, Cengiz OK, Varli M, Cinar E, Atli T. Sarcopenia prevalence and factors associated with sarcopenia in older people living in a nursing home in Ankara Turkey. Geriatr Gerontol Int 2016;16(8):903–10CrossRefPubMed
24.
Zurück zum Zitat Landi F, Liperoti R, Fusco D et al. Prevalence and risk factors of sarcopenia among nursing home older residents. J Gerontol A Biol Sci Med Sci 2012;67(1):48–55CrossRefPubMed Landi F, Liperoti R, Fusco D et al. Prevalence and risk factors of sarcopenia among nursing home older residents. J Gerontol A Biol Sci Med Sci 2012;67(1):48–55CrossRefPubMed
25.
Zurück zum Zitat Bijlsma AY, Meskers CG, Ling CH et al. Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort. Age (Omaha) 2013;35: 871–881CrossRef Bijlsma AY, Meskers CG, Ling CH et al. Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort. Age (Omaha) 2013;35: 871–881CrossRef
26.
Zurück zum Zitat Vasconcelos KS, Dias JM, Bastone A et al. Handgrip strength cutoff points to identify mobility limitation in community-dwelling older people and associated factors. J Nutr Health Aging 2016;20(3):306–15CrossRefPubMed Vasconcelos KS, Dias JM, Bastone A et al. Handgrip strength cutoff points to identify mobility limitation in community-dwelling older people and associated factors. J Nutr Health Aging 2016;20(3):306–15CrossRefPubMed
27.
Zurück zum Zitat Masanés F, Rojano I, Luque X et al. Cut-off points for muscle mass — not grip strength or gait speed — determine variations in sarcopenia prevalence. J Nutr Health Aging 2017;21(7):825–829CrossRefPubMed Masanés F, Rojano I, Luque X et al. Cut-off points for muscle mass — not grip strength or gait speed — determine variations in sarcopenia prevalence. J Nutr Health Aging 2017;21(7):825–829CrossRefPubMed
28.
Zurück zum Zitat Legrand D, Vaes B, Matheï C, Swine C, Degryse JM. The prevalence of sarcopenia in very old individuals according to the European consensus definition: insights from the BELFRAIL study. Age Ageing 2013;42(6):727–34CrossRefPubMed Legrand D, Vaes B, Matheï C, Swine C, Degryse JM. The prevalence of sarcopenia in very old individuals according to the European consensus definition: insights from the BELFRAIL study. Age Ageing 2013;42(6):727–34CrossRefPubMed
29.
Zurück zum Zitat Mijnarends DM, Meijers JM, Halfens R.J et al. Validity and reliability of tools to measure muscle mass, strength, and physical performance in community-dwelling older people: a systematic review. J Am Med Dir Assoc 2013;14(3):170–8CrossRefPubMed Mijnarends DM, Meijers JM, Halfens R.J et al. Validity and reliability of tools to measure muscle mass, strength, and physical performance in community-dwelling older people: a systematic review. J Am Med Dir Assoc 2013;14(3):170–8CrossRefPubMed
30.
Zurück zum Zitat Sayer, AA. Sarcopenia the new geriatric giant: Time to translate research findings into clinical practice. Age Ageing 2014;43: 736–737.CrossRefPubMed Sayer, AA. Sarcopenia the new geriatric giant: Time to translate research findings into clinical practice. Age Ageing 2014;43: 736–737.CrossRefPubMed
Metadaten
Titel
Diagnosis of Sarcopenia in Long-Term Care Homes for the Elderly: The Sensitivity and Specificity of Two Simplified Algorithms with Respect to the EWGSOP Consensus
verfasst von
A. I. Rodriguez-Rejon
Reyes Artacho
A. Puerta
A. Zuñiga
M. D. Ruiz-Lopez
Publikationsdatum
19.02.2018
Verlag
Springer Paris
Erschienen in
The journal of nutrition, health & aging / Ausgabe 7/2018
Print ISSN: 1279-7707
Elektronische ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-018-1004-x

Weitere Artikel der Ausgabe 7/2018

The journal of nutrition, health & aging 7/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.